Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Centre Oscar Lambret
Children's Hospital of Philadelphia
Centre Antoine Lacassagne
Centre Hospitalier Universitaire de Nice
Herlev and Gentofte Hospital
National Cancer Institute (NCI)
University of New Mexico
Elsan
Hoffmann-La Roche
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, Cancer Campus, Grand Paris
Yale University
National Cancer Institute (NCI)
University of Sao Paulo